{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:09:07Z","timestamp":1790701747425,"version":"4.1.0"},"reference-count":63,"publisher":"Rockefeller University Press","issue":"5","license":[{"start":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T00:00:00Z","timestamp":1524787200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.rupress.org\/terms\/"},{"start":{"date-parts":[[2018,11,4]],"date-time":"2018-11-04T00:00:00Z","timestamp":1541289600000},"content-version":"vor","delay-in-days":191,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001744","name":"Mayday Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["6241-13"],"award-info":[{"award-number":["6241-13"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM008306"],"award-info":[{"award-number":["GM008306"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["RO1NS064289"],"award-info":[{"award-number":["RO1NS064289"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01GM043880"],"award-info":[{"award-number":["R01GM043880"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016059"],"award-info":[{"award-number":["P30 CA016059"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rupress.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,5,7]]},"abstract":"<jats:p>The development of chemotherapy-induced painful peripheral neuropathy is a major dose-limiting side effect of many chemotherapeutics, including bortezomib, but the mechanisms remain poorly understood. We now report that bortezomib causes the dysregulation of de novo sphingolipid metabolism in the spinal cord dorsal horn to increase the levels of sphingosine-1-phosphate (S1P) receptor 1 (S1PR1) ligands, S1P and dihydro-S1P. Accordingly, genetic and pharmacological disruption of S1PR1 with multiple S1PR1 antagonists, including FTY720, blocked and reversed neuropathic pain. Mice with astrocyte-specific alterations of S1pr1 did not develop neuropathic pain and lost their ability to respond to S1PR1 inhibition, strongly implicating astrocytes as a primary cellular substrate for S1PR1 activity. At the molecular level, S1PR1 engaged astrocyte-driven neuroinflammation and altered glutamatergic homeostasis, processes blocked by S1PR1 antagonism. Our findings establish S1PR1 as a target for therapeutic intervention and provide insight into cellular and molecular pathways. As FTY720 also shows promising anticancer potential and is FDA approved, rapid clinical translation of our findings is anticipated.<\/jats:p>","DOI":"10.1084\/jem.20170584","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T08:45:09Z","timestamp":1524818709000},"page":"1301-1313","update-policy":"https:\/\/doi.org\/10.1084\/jem.crossmarkpolicy","source":"Crossref","is-referenced-by-count":142,"title":["Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain"],"prefix":"10.1084","volume":"215","author":[{"given":"Katherine","family":"Stockstill","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, MO 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4874-6453","authenticated-orcid":true,"given":"Timothy M.","family":"Doyle","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, MO 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xisheng","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, GA 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhoumou","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, MO 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kali","family":"Janes","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, MO 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua W.","family":"Little","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, MO 1"},{"name":"Department of Surgery, Center for Anatomical Science and Education, Saint Louis University School of Medicine, St. Louis, MO 3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Braden","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, MO 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena","family":"Lauro","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, MO 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigino Antonio","family":"Giancotti","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, MO 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9907-0441","authenticated-orcid":true,"given":"Caron Mitsue","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, MO 1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchi","family":"Yadav","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, GA 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen Hua","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University of California, San Diego, La Jolla, CA 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0245-1417","authenticated-orcid":true,"given":"Jack M.","family":"Lionberger","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology, Oncology, and Cellular Therapeutics, Saint Louis University School of Medicine, St. Louis, MO 5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7708-5565","authenticated-orcid":true,"given":"William L.","family":"Neumann","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, School of Pharmacy, Southern Illinois University Edwardsville, Edwardsville, IL 6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary J.","family":"Bennett","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, University of California, San Diego, La Jolla, CA 4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Rong","family":"Weng","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, GA 2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Spiegel","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, School of Medicine, Richmond, VA 7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2062-2782","authenticated-orcid":true,"given":"Daniela","family":"Salvemini","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Physiology, Saint Louis University School of Medicine, St. Louis, MO 1"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"291","published-online":{"date-parts":[[2018,4,27]]},"reference":[{"key":"2023072604131733200_bib1","first-page":"2615","article-title":"Proteasome inhibitors: a novel class of potent and effective antitumor agents","volume":"59","author":"Adams","year":"1999","journal-title":"Cancer Res."},{"key":"2023072604131733200_bib2","doi-asserted-by":"publisher","first-page":"6893","DOI":"10.1182\/blood-2011-06-363879","article-title":"FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death","volume":"118","author":"Alinari","year":"2011","journal-title":"Blood."},{"key":"2023072604131733200_bib3","doi-asserted-by":"publisher","first-page":"9722","DOI":"10.1021\/jm3009508","article-title":"An oral sphingosine 1-phosphate receptor 1 (S1P(1)) antagonist prodrug with efficacy in vivo: discovery, synthesis, and evaluation","volume":"55","author":"Angst","year":"2012","journal-title":"J. Med. Chem."},{"key":"2023072604131733200_bib4","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1158\/1078-0432.CCR-15-2618","article-title":"The sphingosine-1-phosphate modulator FTY720 targets multiple myeloma via the CXCR4\/CXCL12 pathway","volume":"23","author":"Beider","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"2023072604131733200_bib5","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.bbalip.2013.11.001","article-title":"Second generation S1P pathway modulators: research strategies and clinical developments","volume":"1841","author":"Bigaud","year":"2014","journal-title":"Biochim. Biophys. Acta."},{"key":"2023072604131733200_bib6","doi-asserted-by":"publisher","first-page":"4198","DOI":"10.1021\/jm100181s","article-title":"2-imino-thiazolidin-4-one derivatives as potent, orally active S1P1 receptor agonists","volume":"53","author":"Bolli","year":"2010","journal-title":"J. Med. Chem."},{"key":"2023072604131733200_bib7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2217\/pmt.15.19","article-title":"Mechanisms involved in the development of chemotherapy-induced neuropathy","volume":"5","author":"Boyette-Davis","year":"2015","journal-title":"Pain Manag."},{"key":"2023072604131733200_bib8","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nrd3248","article-title":"Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis","volume":"9","author":"Brinkmann","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"2023072604131733200_bib9","doi-asserted-by":"publisher","first-page":"e72995","DOI":"10.1371\/journal.pone.0072995","article-title":"Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse","volume":"8","author":"Carozzi","year":"2013","journal-title":"PLoS One."},{"key":"2023072604131733200_bib10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2174\/156800911794519752","article-title":"Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives","volume":"11","author":"Chen","year":"2011","journal-title":"Curr. Cancer Drug Targets."},{"key":"2023072604131733200_bib11","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1152\/jn.00709.2010","article-title":"The sphingosine 1-phosphate receptor, S1PR1, plays a prominent but not exclusive role in enhancing the excitability of sensory neurons","volume":"104","author":"Chi","year":"2010","journal-title":"J. Neurophysiol."},{"key":"2023072604131733200_bib12","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1073\/pnas.1014154108","article-title":"FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation","volume":"108","author":"Choi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2023072604131733200_bib13","first-page":"803","article-title":"Neuropathic pain and cytokines: current perspectives","volume":"6","author":"Clark","year":"2013","journal-title":"J. Pain Res."},{"key":"2023072604131733200_bib14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/85879","article-title":"Mutations in SPTLC1, encoding serine palmitoyltransferase, long chain base subunit-1, cause hereditary sensory neuropathy type I","volume":"27","author":"Dawkins","year":"2001","journal-title":"Nat. Genet."},{"key":"2023072604131733200_bib15","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1016\/j.bbamem.2006.08.017","article-title":"Inhibitors of sphingolipid metabolism enzymes","volume":"1758","author":"Delgado","year":"2006","journal-title":"Biochim. Biophys. Acta."},{"key":"2023072604131733200_bib16","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1158\/1055-9965.EPI-12-1356","article-title":"Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care","volume":"22","author":"de Moor","year":"2013","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"2023072604131733200_bib17","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev.pa.20.040180.002301","article-title":"Efficient analysis of experimental observations","volume":"20","author":"Dixon","year":"1980","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"2023072604131733200_bib18","doi-asserted-by":"publisher","first-page":"4812","DOI":"10.1111\/bph.14063","article-title":"Characterization of a rat model of bortezomib-induced painful neuropathy","volume":"174","author":"Duggett","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"2023072604131733200_bib19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/SPC.0b013e328342f9cc","article-title":"Chemotherapy-induced neuropathic pain","volume":"5","author":"Farquhar-Smith","year":"2011","journal-title":"Curr. Opin. Support. Palliat. Care."},{"key":"2023072604131733200_bib20","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.neuropharm.2014.08.004","article-title":"Spinal administration of mGluR5 antagonist prevents the onset of bortezomib induced neuropathic pain in rat","volume":"86","author":"Ghelardini","year":"2014","journal-title":"Neuropharmacology."},{"key":"2023072604131733200_bib21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00280-013-2318-3","article-title":"Bortezomib-induced apoptosis in cultured pancreatic cancer cells is associated with ceramide production","volume":"73","author":"Gong","year":"2014","journal-title":"Cancer Chemother. Pharmacol."},{"key":"2023072604131733200_bib22","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.1176709","article-title":"Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate","volume":"325","author":"Hait","year":"2009","journal-title":"Science."},{"key":"2023072604131733200_bib23","doi-asserted-by":"publisher","first-page":"e156","DOI":"10.1038\/oncsis.2015.16","article-title":"The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ER\u03b1 expression and enhances hormonal therapy for breast cancer","volume":"4","author":"Hait","year":"2015","journal-title":"Oncogenesis."},{"key":"2023072604131733200_bib24","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fphar.2013.00156","article-title":"Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN)","volume":"4","author":"Han","year":"2013","journal-title":"Front. Pharmacol."},{"key":"2023072604131733200_bib25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2023072604131733200_bib26","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1016\/j.pain.2013.07.032","article-title":"Bioenergetic deficits in peripheral nerve sensory axons during chemotherapy-induced neuropathic pain resulting from peroxynitrite-mediated post-translational nitration of mitochondrial superoxide dismutase","volume":"154","author":"Janes","year":"2013","journal-title":"Pain."},{"key":"2023072604131733200_bib27","doi-asserted-by":"publisher","first-page":"21082","DOI":"10.1074\/jbc.M114.569574","article-title":"The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1","volume":"289","author":"Janes","year":"2014","journal-title":"J. Biol. Chem."},{"key":"2023072604131733200_bib28","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.1523\/JNEUROSCI.3338-07.2008","article-title":"Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord","volume":"28","author":"Kawasaki","year":"2008","journal-title":"J. Neurosci."},{"key":"2023072604131733200_bib29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1750-3639.2011.00501.x","article-title":"Aberrant upregulation of astroglial ceramide potentiates oligodendrocyte injury","volume":"22","author":"Kim","year":"2012","journal-title":"Brain Pathol."},{"key":"2023072604131733200_bib30","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.4049\/jimmunol.1203428","article-title":"IL-1\u03b2 and TLR4 signaling are involved in the aggravated murine acute graft-versus-host disease caused by delayed bortezomib administration","volume":"192","author":"Liang","year":"2014","journal-title":"J. Immunol."},{"key":"2023072604131733200_bib31","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1523\/JNEUROSCI.19-04-01263.1999","article-title":"Rapid, activation-induced redistribution of ionotropic glutamate receptors in cultured hippocampal neurons","volume":"19","author":"Lissin","year":"1999","journal-title":"J. Neurosci."},{"key":"2023072604131733200_bib32","doi-asserted-by":"publisher","first-page":"10797","DOI":"10.1523\/JNEUROSCI.6345-11.2012","article-title":"Supraspinal peroxynitrite modulates pain signaling by suppressing the endogenous opioid pathway","volume":"32","author":"Little","year":"2012","journal-title":"J. Neurosci."},{"key":"2023072604131733200_bib33","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nature13475","article-title":"Sphingolipid metabolites in inflammatory disease","volume":"510","author":"Maceyka","year":"2014","journal-title":"Nature."},{"key":"2023072604131733200_bib34","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/j.1471-4159.2007.04629.x","article-title":"Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors","volume":"102","author":"Mullershausen","year":"2007","journal-title":"J. Neurochem."},{"key":"2023072604131733200_bib35","doi-asserted-by":"publisher","first-page":"15400","DOI":"10.1523\/JNEUROSCI.2391-10.2010","article-title":"Counter-regulation of opioid analgesia by glial-derived bioactive sphingolipids","volume":"30","author":"Muscoli","year":"2010","journal-title":"J. Neurosci."},{"key":"2023072604131733200_bib36","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1152\/jn.01172.2002","article-title":"Distinct roles of P2X receptors in modulating glutamate release at different primary sensory synapses in rat spinal cord","volume":"89","author":"Nakatsuka","year":"2003","journal-title":"J. Neurophysiol."},{"key":"2023072604131733200_bib37","doi-asserted-by":"publisher","first-page":"4144","DOI":"10.1172\/JCI68951","article-title":"PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells","volume":"123","author":"Neviani","year":"2013","journal-title":"J. Clin. Invest."},{"key":"2023072604131733200_bib38","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1152\/jn.91138.2008","article-title":"Glutamate transporters prevent excessive activation of NMDA receptors and extrasynaptic glutamate spillover in the spinal dorsal horn","volume":"101","author":"Nie","year":"2009","journal-title":"J. Neurophysiol."},{"key":"2023072604131733200_bib39","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.neuropharm.2016.11.006","article-title":"Sphingosine-1-phosphate receptor therapies: Advances in clinical trials for CNS-related diseases","volume":"113","author":"O\u2019Sullivan","year":"2017","journal-title":"Neuropharmacology."},{"key":"2023072604131733200_bib40","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/nrc1411","article-title":"Biologically active sphingolipids in cancer pathogenesis and treatment","volume":"4","author":"Ogretmen","year":"2004","journal-title":"Nat. Rev. Cancer."},{"key":"2023072604131733200_bib41","volume-title":"The rat brain in stereotaxic coordinates.","author":"Paxinos","year":"1998"},{"key":"2023072604131733200_bib42","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.neuroscience.2014.05.051","article-title":"Astrocytes, but not microglia, are activated in oxaliplatin and bortezomib-induced peripheral neuropathy in the rat","volume":"274","author":"Robinson","year":"2014","journal-title":"Neuroscience."},{"key":"2023072604131733200_bib43","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1073\/pnas.1615413114","article-title":"Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation","volume":"114","author":"Rothhammer","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2023072604131733200_bib44","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.tips.2012.12.001","article-title":"Therapeutic targeting of the ceramide-to-sphingosine 1-phosphate pathway in pain","volume":"34","author":"Salvemini","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"2023072604131733200_bib45","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods."},{"key":"2023072604131733200_bib46","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ab.2009.06.004","article-title":"Multiple reprobing of Western blots after inactivation of peroxidase activity by its substrate, hydrogen peroxide","volume":"393","author":"Sennepin","year":"2009","journal-title":"Anal. Biochem."},{"key":"2023072604131733200_bib47","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrc2507","article-title":"Cytokines and their relationship to the symptoms and outcome of cancer","volume":"8","author":"Seruga","year":"2008","journal-title":"Nat. Rev. Cancer."},{"key":"2023072604131733200_bib48","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.expneurol.2006.05.007","article-title":"Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells","volume":"201","author":"Siau","year":"2006","journal-title":"Exp. Neurol."},{"key":"2023072604131733200_bib49","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.biochi.2010.02.008","article-title":"Sphingosine kinase: Role in regulation of bioactive sphingolipid mediators in inflammation","volume":"92","author":"Snider","year":"2010","journal-title":"Biochimie."},{"key":"2023072604131733200_bib50","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1124\/mol.64.5.1199","article-title":"Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes","volume":"64","author":"Sorensen","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"2023072604131733200_bib51","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/nri2974","article-title":"The outs and the ins of sphingosine-1-phosphate in immunity","volume":"11","author":"Spiegel","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"2023072604131733200_bib52","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/978-1-4419-6741-1_10","article-title":"Extracellular and intracellular actions of sphingosine-1-phosphate","volume":"688","author":"Strub","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"2023072604131733200_bib53","first-page":"13","article-title":"T-cell activation is enhanced by targeting IL-10 cytokine production in toll-like receptor-stimulated macrophages","volume":"1","author":"Walk","year":"2012","journal-title":"ImmunoTargets Ther."},{"key":"2023072604131733200_bib54","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.neuroscience.2005.11.061","article-title":"Inhibition of glutamate uptake in the spinal cord induces hyperalgesia and increased responses of spinal dorsal horn neurons to peripheral afferent stimulation","volume":"138","author":"Weng","year":"2006","journal-title":"Neuroscience."},{"key":"2023072604131733200_bib55","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.neuroscience.2007.07.063","article-title":"Glial glutamate transporter 1 regulates the spatial and temporal coding of glutamatergic synaptic transmission in spinal lamina II neurons","volume":"149","author":"Weng","year":"2007","journal-title":"Neuroscience."},{"key":"2023072604131733200_bib56","doi-asserted-by":"publisher","first-page":"23106","DOI":"10.18632\/oncotarget.7145","article-title":"The emerging role of FTY720 (Fingolimod) in cancer treatment","volume":"7","author":"White","year":"2016","journal-title":"Oncotarget."},{"key":"2023072604131733200_bib57","doi-asserted-by":"publisher","first-page":"30544","DOI":"10.1074\/jbc.M113.495465","article-title":"Endogenous interleukin-1\u03b2 in neuropathic rats enhances glutamate release from the primary afferents in the spinal dorsal horn through coupling with presynaptic N-methyl-D-aspartic acid receptors","volume":"288","author":"Yan","year":"2013","journal-title":"J. Biol. Chem."},{"key":"2023072604131733200_bib58","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1113\/jphysiol.2012.250522","article-title":"Endogenous activation of presynaptic NMDA receptors enhances glutamate release from the primary afferents in the spinal dorsal horn in a rat model of neuropathic pain","volume":"591","author":"Yan","year":"2013","journal-title":"J. Physiol."},{"key":"2023072604131733200_bib59","first-page":"18","article-title":"The blood brain barrier and the role of cytokines in neuropsychiatry","volume":"6","author":"Yarlagadda","year":"2009","journal-title":"Psychiatry (Edgmont Pa.)."},{"key":"2023072604131733200_bib60","doi-asserted-by":"publisher","first-page":"7478","DOI":"10.1158\/0008-5472.CAN-05-0850","article-title":"FTY720 induces apoptosis in multiple myeloma cells and overcomes drug resistance","volume":"65","author":"Yasui","year":"2005","journal-title":"Cancer Res."},{"key":"2023072604131733200_bib61","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1152\/jn.1989.62.1.96","article-title":"Primary afferent-evoked synaptic responses and slow potential generation in rat substantia gelatinosa neurons in vitro","volume":"62","author":"Yoshimura","year":"1989","journal-title":"J. Neurophysiol."},{"key":"2023072604131733200_bib62","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","article-title":"An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex","volume":"34","author":"Zhang","year":"2014","journal-title":"J. Neurosci."},{"key":"2023072604131733200_bib63","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.expneurol.2012.08.023","article-title":"Mitotoxicity and bortezomib-induced chronic painful peripheral neuropathy","volume":"238","author":"Zheng","year":"2012","journal-title":"Exp. Neurol."}],"container-title":["Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/215\/5\/1301\/1759101\/jem_20170584.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/rupress.org\/jem\/article-pdf\/215\/5\/1301\/1759101\/jem_20170584.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:18:32Z","timestamp":1690330712000},"score":1,"resource":{"primary":{"URL":"https:\/\/rupress.org\/jem\/article\/215\/5\/1301\/42551\/Dysregulation-of-sphingolipid-metabolism"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,27]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5,7]]}},"URL":"https:\/\/doi.org\/10.1084\/jem.20170584","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733126348.793571732","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.733126348.793556744","asserted-by":"object"}]},"ISSN":["0022-1007","1540-9538"],"issn-type":[{"value":"0022-1007","type":"print"},{"value":"1540-9538","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,27]]}}}